Health care “affordability” is a top concern for most Americans, but it means different things to different people. Affordability can be examined as an economic concept, a policy threshold, or through the decisions made by individuals and families. As part of Penn LDI's research partnership with United States of Care, we have developed a brief that explores the concept of affordability through these different lenses, and outlines key issues for policymakers to consider as they try to tackle this pressing problem. It is the first in a series that will examine the cost burden of health care in the United States.
As state legislatures continue to reassess restrictions on the scope of practice of Advanced Practice Registered Nurses (APRNs), Daniel Gilman of the Federal Trade Commission (FTC) will give us his perspectives on how nursing regulations affect competition at the LDI Health Policy seminar on Friday, December 8, 2017 at noon.
In repeated surveys, Americans cite the affordability of health care as their top financial concern. Despite their handwringing, politicians often avoid defining what constitutes “affordable” health care, and both non-experts and seasoned policymakers seem to lack robust measures of affordability. How can the most important crisis in health care lack reliable metrics?
The Food and Drug Administration (FDA) recently approved the first digital pill that tracks if patients have taken their medication. Our experts weighed in on the potential benefits of the new technology, as well as on the potential for abuse.
The Commission on Evidence-Based Policymaking issued a final report in September whose recommendations are rapidly making their way into bipartisan legislation. But there are two harder questions on which the report is silent.
LDI’s 50th Anniversary Symposium convened nearly 450 attendees, including foremost experts in health policy, academia, and industry, to discuss solutions to today's most pressing health care challenges. The two-day event covered topics ranging from innovative population health solutions to redesigning health care delivery and payment. If you missed the dialogue, here are some highlights.
At LDI’s 50th Anniversary Symposium, participants in the panel “The Future of Payment Reform” characterized and evaluated different alternative payment models (APMs) such as bundled payments and accountable care organizations (ACOs).
Federal policies have failed to recognize that opioid use disorder is a chronic disease and not a crime. It is time to let public health take the lead on the opioid epidemic. The country must implement evidence-based public health policies that end the war and start the healing.
The recent rule change by the Trump administration that makes it easier for employers to refuse to include free contraceptive services in their health insurance plans taps into a wider debate about privileging religious and moral freedom over other interests in policy. In a recent Journal of the American Medical Association (JAMA) Viewpoint, Ronit Stahl and LDI Senior Fellow Holly Fernandez Lynch describe how policymakers have competing duties to protect religious and moral freedom (conscience) while serving other needs of people with different beliefs (access).
Reforming Medicare to protect the health of an aging and vulnerable population is a pressing policy concern. To share some perspective, Dr. Mary Naylor led a panel entitled “Shaping the Future of Medicare” at Penn LDI’s 50th Anniversary Symposium.
LDI’s 50th anniversary symposium convened a panel to elucidate key questions for the future of value frameworks—what does value mean to different stakeholders in the health care system? How should payers, doctors, and patients appraise the value of the care they receive? What does the future hold for value frameworks in the United States?